Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.45K Buy
+11
New +$2K ﹤0.01% 977
2024
Q4
– Sell
-66
Closed -$10.8K – 686
2024
Q3
$10.8K Hold
66
– – ﹤0.01% 482
2024
Q2
$9.15K Hold
66
– – ﹤0.01% 712
2024
Q1
$9.11K Hold
66
– – ﹤0.01% 630
2023
Q4
$6.92K Buy
+66
New +$6.1K ﹤0.01% 236
2023
Q1
– Sell
-15
Closed -$1.12K – 875
2022
Q4
$1.12K Sell
15
-56
-79% -$4.35K ﹤0.01% 915
2022
Q3
$6K Buy
71
+7
+11% +$614 ﹤0.01% 790
2022
Q2
$5K Buy
+64
New +$6.48K ﹤0.01% 747
2020
Q4
– Sell
-20
Closed -$2K – 509
2020
Q3
$2K Buy
+20
New +$1.71K ﹤0.01% 492

Other funds holding DVA

Crewe Advisors's DVA Position: Q2 2026 in Review

Crewe Advisors opened a new position in DaVita (DVA) in Q2 2026: 11 shares worth $2.45K. The stake represents ﹤0.01% of the portfolio and ranks #977 among its holdings. This is a return to the name: Crewe Advisors previously reported a position in DVA as recently as Q3 2024.

Crewe Advisors first reported a position in DVA in Q3 2020 and has held it in 9 quarters since. The position peaked at $10.8K in Q3 2024. 631 funds tracked by Wall St. Rank hold DVA as of Q2 2026.

  • Crewe Advisors held 11 shares of DaVita worth $2.45K as of Q2 2026.
  • DaVita was a new Crewe Advisors position in Q2 2026.
  • DaVita made up ﹤0.01% of Crewe Advisors's portfolio in Q2 2026, its #977 holding.
  • Crewe Advisors first reported a position in DaVita in Q3 2020 and has held it in 9 quarters since.
  • Crewe Advisors's DaVita position peaked at $10.8K in Q3 2024.
  • 631 funds tracked by Wall St. Rank held DaVita as of Q2 2026.

Based on Crewe Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.